Fetal Alcohol Spectrum Disorder and Pediatric Neurology: Are We Missing the Connection? A Scoping Review

Michael Burd1, James Miles2, Graysen Myers1

  • 1Department of Pediatrics, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND, USA.

Journal of Child Neurology
|December 24, 2024
PubMed

Insights

Pediatric neurology journals give little attention to fetal alcohol spectrum disorder (FASD), despite its high prevalence. This study found FASD is common in clinics, suggesting journals should increase coverage for better diagnosis and care.

Area of Science:

  • Pediatric Neurology
  • Neurodevelopmental Disorders
  • Public Health

Background:

  • Pediatric neurology addresses complex developmental disorders, including ADHD and autism spectrum disorder (ASD).
  • Fetal alcohol spectrum disorder (FASD) is a common neurodevelopmental condition, affecting 1-5% of school-aged children.
  • Current literature in pediatric neurology journals disproportionately underrepresents FASD compared to ADHD and ASD.

Approach:

  • A scoping review analyzed article prevalence on FASD, ADHD, and ASD in 8 pediatric neurology journals.
  • A chart review examined diagnoses in 40 pediatric patients referred for neurobehavioral disorder assessment.
  • Data were collected on diagnoses of ADHD, ASD, and FASD, including comorbidities.

Key Points:

  • Journal analysis revealed only 3.3% of articles focused on FASD, compared to 58.4% for ASD and 38.4% for ADHD.
  • In a clinical sample, 20% received an FASD diagnosis, with 40% having prenatal alcohol exposure.
  • High comorbidity rates were observed: 21% for FASD and ADHD, and 2.5% for FASD and ASD.

Conclusions:

  • FASD is a significant and common neurodevelopmental disorder often overlooked in pediatric neurology literature.
  • The findings indicate FASD is likely underdiagnosed in clinical practice, similar to ADHD and ASD.
  • Pediatric neurology journals should increase FASD content to promote early recognition and intervention, improving patient and family outcomes.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...